Options for treating postherpetic neuralgia in the medically complicated patient

References

• OpsteltenWMauritzJWde WitNJvan WijckAJStalmanWAvan EssenGAHerpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research databaseFam Pract200219547147512356697
   PubMed Web of Science ®Google Scholar
• YawnBPSaddierPWollanPCSt SauverJLKurlandMJSyLSA population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introductionMayo Clin Proc200782111341134917976353
   PubMed Web of Science ®Google Scholar
• RogerVLGoASLloyd-JonesDMAmerican Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics – 2012 update: a report from the American Heart AssociationCirculation2012125118819722215894
   PubMed Web of Science ®Google Scholar
• LindemanRDTobinJShockNWLongitudinal studies on the rate of decline in renal function with ageJ Am Geriatr Soc19853342782853989190
   PubMed Web of Science ®Google Scholar
• RoweJWAndresRTobinJDNorrisAHShockNWThe effect of age on creatinine clearance in men: a cross-sectional and longitudinal studyJ Gerontol19763121551631249404
   PubMedGoogle Scholar
• WynneHACopeLHMutchERawlinsMDWoodhouseKWJamesOFThe effect of age upon liver volume and apparent liver blood flow in healthy manHepatology1989922973012643548
   PubMed Web of Science ®Google Scholar
• QatoDMAlexanderGCContiRMJohnsonMSchummPLindauSTUse of prescription and over-the-counter medications and dietary supplements among older adults in the United StatesJAMA2008300242867287819109115
   PubMed Web of Science ®Google Scholar
• PreskornSHSilkeyBShahRComplexity of medication use in the Veterans Affairs healthcare system: Part I: Outpatient use in relation to age and number of prescribersJ Psychiatr Pract200511151515650617
   PubMedGoogle Scholar
• TulnerLRFrankfortSVGijsenGJvan CampenJPKoksCHBeijnenJHDrug–drug interactions in a geriatric outpatient cohort: prevalence and relevanceDrugs Aging200825434335518361544
   PubMed Web of Science ®Google Scholar
• DworkinRHO’ConnorABAudetteJRecommendations for the pharmacological management of neuropathic pain: an overview and literature updateMayo Clin Proc201085Suppl 3S3S1420194146
   PubMed Web of Science ®Google Scholar
• ArgoffCEReview of current guidelines on the care of postherpetic neuralgiaPostgrad Med2011123513414221904096
   PubMed Web of Science ®Google Scholar
• DubinskyRMKabbaniHEl-ChamiZBoutwellCAliHQuality Standards Subcommittee of the American Academy of NeurologyPractice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of NeurologyNeurology200463695996515452284
   PubMed Web of Science ®Google Scholar
• AttalNCruccuGBaronREuropean Federation of Neurological SocietiesEFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revisionEur J Neurol20101791113e8820402746
   PubMed Web of Science ®Google Scholar
• MoulinDEClarkAJGilronICanadian Pain SocietyPharmacological management of chronic neuropathic pain – consensus statement and guidelines from the Canadian Pain SocietyPain Res Manag2007121132117372630
   PubMed Web of Science ®Google Scholar
• DworkinRHO’ConnorABBackonjaMPharmacologic management of neuropathic pain: evidence-based recommendationsPain2007132323725117920770
   PubMed Web of Science ®Google Scholar
• FinnerupNBOttoMMcQuayHJJensenTSSindrupSHAlgorithm for neuropathic pain treatment: an evidence based proposalPain2005118328930516213659
   PubMed Web of Science ®Google Scholar
• HempenstallKNurmikkoTJJohnsonRWA’HernRPRiceASAnalgesic therapy in postherpetic neuralgia: a quantitative systematic reviewPLoS Med200527e16416013891
   PubMed Web of Science ®Google Scholar
• SaartoTWiffenPJAntidepressants for neuropathic pain: a Cochrane reviewJ Neurol Neurosurg Psychiatr201081121372137320543189
   PubMed Web of Science ®Google Scholar
• SindrupSHOttoMFinnerupNBJensenTSAntidepressants in the treatment of neuropathic painBasic Clin Pharmacol Toxicol200596639940915910402
   PubMed Web of Science ®Google Scholar
• CohenHWGibsonGAldermanMHExcess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agentsAm J Med200010812811059434
   PubMed Web of Science ®Google Scholar
• RayWAMeredithSThapaPBHallKMurrayKTCyclic antidepressants and the risk of sudden cardiac deathClin Pharmacol Ther200475323424115001975
   PubMed Web of Science ®Google Scholar
• TataLJWestJSmithCGeneral population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepres-sants on the risk of acute myocardial infarctionHeart200591446547115772201
   PubMed Web of Science ®Google Scholar
• MooreRAStraubeSWiffenPJDerrySMcQuayHJPregabalin for acute and chronic pain in adultsCochrane Database Syst Rev2009CD00707619588419
   PubMedGoogle Scholar
• MooreRAWiffenPJDerrySMcQuayHJGabapentin for chronic neuropathic pain and fibromyalgia in adultsCochrane Database Syst Rev2011CD00793821412914
   PubMed Web of Science ®Google Scholar
• ParsonsBTiveLHuangSGabapentin: a pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgiaAm J Geriatr Pharmacother20042315716215561647
   PubMedGoogle Scholar
• SemelDMurphyTKZlatevaGCheungREmirBEvaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studiesBMC Fam Pract2010118521054853
   PubMed Web of Science ®Google Scholar
• BinderABruxelleJRogersPHansGBöslIBaronRTopical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trialClin Drug Investig2009296393408
   PubMed Web of Science ®Google Scholar
• HansGSabatowskiRBinderABoeslIRogersPBaronREfficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term studyCurr Med Res Opin20092551295130519366301
   PubMed Web of Science ®Google Scholar
• BaronRMayoralVLeijonGBinderASteigerwaldISerpellM5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT studyCurr Med Res Opin20092571663167619485723
   PubMed Web of Science ®Google Scholar
• RehmSBinderABaronRPost-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness studyCurr Med Res Opin20102671607161920429825
   PubMed Web of Science ®Google Scholar
• WatsonCPBabulNEfficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgiaNeurology1998506183718419633737
   PubMed Web of Science ®Google Scholar
• RajaSNHaythornthwaiteJAPappagalloMOpioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trialNeurology20025971015102112370455
   PubMed Web of Science ®Google Scholar
• BhambBBrownDHariharanJAndersonJBalousekSFlemingMFSurvey of select practice behaviors by primary care physicians on the use of opioids for chronic painCurr Med Res Opin20062291859186516968589
   PubMed Web of Science ®Google Scholar
• SpitzAMooreAAPapaleontiouMGranieriETurnerBJReidMCPrimary care providers’ perspective on prescribing opioids to older adults with chronic non-cancer pain: a qualitative studyBMC Geriatr2011113521752299
   PubMed Web of Science ®Google Scholar
• UpshurCCLuckmannRSSavageauJAPrimary care provider concerns about management of chronic pain in community clinic populationsJ Gen Intern Med200621665265516808752
   PubMed Web of Science ®Google Scholar
• BoureauFLegallicierPKabir-AhmadiMTramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trialPain20031041–232333112855342
   PubMed Web of Science ®Google Scholar
• NUCYNTA® ER (tapentadol) [prescribing information]Titusville. NJJanssen Pharmaceuticals, Inc2011
   Google Scholar
• AfilaloMEtropolskiMSKuperwasserBEfficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoar-thritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III studyClin Drug Investig2010308489505
   PubMed Web of Science ®Google Scholar
• LangeBKuperwasserBOkamotoAEfficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back painAdv Ther201027638139920556560
   PubMed Web of Science ®Google Scholar
• NolanoMSimoneDAWendelschafer-CrabbGJohnsonTHazenEKennedyWRTopical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensationPain1999811–213514510353501
   PubMed Web of Science ®Google Scholar
• DerrySLloydRMooreRAMcQuayHJTopical capsaicin for chronic neuropathic pain in adultsCochrane Database Syst Rev2009CD00739319821411
   PubMed Web of Science ®Google Scholar
• BackonjaMWallaceMSBlonskyERNGX-4010 C116 Study GroupNGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind studyLancet Neurol20087121106111218977178
   PubMed Web of Science ®Google Scholar
• BackonjaMMMalanTPVanhoveGFTobiasJKC102/106 Study GroupNGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extensionPain Med201011460060820113411
   PubMed Web of Science ®Google Scholar
• MasonLMooreRADerrySEdwardsJEMcQuayHJSystematic review of topical capsaicin for the treatment of chronic painBMJ2004328744699115033881
   PubMed Web of Science ®Google Scholar
• Qutenza® (capsaicin 8% patch) [prescribing information]San Mateo, CANeurogesX, Inc2009
   Google Scholar
• SchmaderKEBaronRHaanpääMLTreatment considerations for elderly and frail patients with neuropathic painMayo Clin Proc201085Suppl 3S26S3220194145
   PubMed Web of Science ®Google Scholar
• Parsells KellyJCookSFKaufmanDWAndersonTRosenbergLMitchellAAPrevalence and characteristics of opioid use in the US adult populationPain2008138350751318342447
   PubMed Web of Science ®Google Scholar
• SokolKCKnudsenJFLiMMPolypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect managementJ Clin Pharm Ther200732216917517381667
   PubMed Web of Science ®Google Scholar
• FlockhartDADrug interactions: cytochrome P450 drug interaction tableIndiana University School of Medicine [webpage on the Internet] Available from: http://medicine.iupui.edu/flockhart/table.htmAccessed June 20, 2012
   Google Scholar
• ZhouSFXueCCYuXQLiCWangGClinically important drug interactions potentially involving mechanism-based inhibition of cyto-chrome P4503A4 and the role of therapeutic drug monitoringTher Drug Monit200729668771018043468
   PubMed Web of Science ®Google Scholar
• BertilssonLLouYQDuYLPronounced differences between native Chinese and Swedish populations in the polymorphic hydroxy-lations of debrisoquin and S-mephenytoinClin Pharmacol Ther19925143883971345344
   PubMed Web of Science ®Google Scholar
• EvansDAMahgoubASloanTPIdleJRSmithRLA family and population study of the genetic polymorphism of debrisoquine oxidation in a white British populationJ Med Genet19801721021057381862
   PubMed Web of Science ®Google Scholar
• BathumLJohanssonIIngelman-SundbergMHørderMBrøsenKUltrarapid metabolism of sparteine: frequency of alleles with duplicated CYP2D6 genes in a Danish population as determined by restriction fragment length polymorphism and long polymerase chain reactionPharmacogenetics19988211912310022749
   PubMedGoogle Scholar
• LøvlieRDalyAKMolvenAIdleJRSteenVMUltrarapid metabo-lizers of debrisoquine: characterization and PCR-based detection of alleles with duplication of the CYP2D6 geneFEBS Lett1996392130348769309
   PubMed Web of Science ®Google Scholar
• AklilluEPerssonIBertilssonLJohanssonIRodriguesFIngelman-SundbergMFrequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 allelesJ Pharmacol Exp Ther199627814414468764380
   PubMed Web of Science ®Google Scholar
• BathumLSkjelboEMutabingwaTKMadsenHHørderMBrøsenKPhenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian populationBr J Clin Pharmacol199948339540110510152
   PubMed Web of Science ®Google Scholar
• MasimirembwaCPerssonIBertilssonLHaslerJIngelman-SundbergMA novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: association with diminished debrisoquine hydroxylase activityBr J Clin Pharmacol19964267137198971426
   PubMed Web of Science ®Google Scholar
• SohnDRShinSGParkCWKusakaMChibaKIshizakiTMetoprolol oxidation polymorphism in a Korean population: comparison with native Japanese and Chinese populationsBr J Clin Pharmacol19913245045071958447
   PubMed Web of Science ®Google Scholar
• Lyrica® (pregabalin) [prescribing information]New YorkPfizer Inc2011
   Google Scholar
• Neurontin® (gabapentin) [prescribing information]New YorkPfizer Inc2011
   Google Scholar
• CoffmanBLRiosGRKingCDTephlyTRHuman UGT2B7 catalyzes morphine glucuronidationDrug Metab Dispos1997251149010622
   PubMed Web of Science ®Google Scholar
• Dilaudid® (Hydromorphone HCl) [prescribing information]Stamford, CTPurdue Pharma LP2009
   Google Scholar
• OPANA® ER (oxymorphone hydrochloride) [prescribing information]Chadds Ford, PAEndo Pharmaceuticals2012
   Google Scholar
• SmithHBruckenthalPImplications of opioid analgesia for medically complicated patientsDrugs Aging201027541743320450239
   PubMed Web of Science ®Google Scholar
• SmithHSOpioid metabolismMayo Clin Proc200984761362419567715
   PubMed Web of Science ®Google Scholar
• CampbellBJRowbothamMDaviesPSJacobPBenowitzNLSystemic absorption of topical lidocaine in normal volunteers, patients with post-herpetic neuralgia, and patients with acute herpes zosterJ Pharm Sci20029151343135011977110
   PubMed Web of Science ®Google Scholar
• GammaitoniARAlvarezNAGalerBSSafety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literatureJ Clin Pharmacol200343211111712616661
   PubMed Web of Science ®Google Scholar
• GammaitoniARDavisMWPharmacokinetics and tolerability of lidocaine patch 5% with extended dosingAnn Pharmacother200236223624011847940
   PubMed Web of Science ®Google Scholar
• Lidoderm® (lidocaine patch 5%) [prescribing information]Chadds Ford, PAEndo Pharmaceuticals Inc2010
   Google Scholar
• BabbarSMarierJFMouksassiMSPharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic painTher Drug Monit200931450251019494795
   PubMed Web of Science ®Google Scholar
• Amitriptyline hydrochloride [prescribing information]Princeton NJSandoz Inc2011
   Google Scholar
• Nortriptyline hydrochloride [prescribing information]Morgantown, WVMylan Pharmaceuticals Inc2007
   Google Scholar
• Norpramin® (desipramine hydrdochloride) [prescribing information]Bridgewater, NJSanof-Aventis US LLC2011
   Google Scholar
• MahlbergRKunzDSasseJKirchheinerJSerotonin syndrome with tramadol and citalopramAm J Psychiatry20041616112915169709
   PubMed Web of Science ®Google Scholar
• TakeshitaJLitzingerMHSerotonin syndrome associated with tramadolPrim Care Companion J Clin Psychiatry200911527319956471
   PubMedGoogle Scholar
• VizcaychipiMPWalkerSPalazzoMSerotonin syndrome triggered by tramadolBr J Anaesth200799691918006535
   PubMed Web of Science ®Google Scholar
• Ultram ER® (tramadol hydrochloride) [prescribing information]Raritan, NJOrtho-McNeil-Janssen Pharmaceuticals, Inc2009
   Google Scholar
• Center for Drug Evaluation and ResearchGuidance for industry: pharmacokinetics in patients with impaired renal function – study design, data analysis, and impact on dosing and labelingSpringville, MDFood and Drug Administration32010
   Google Scholar
• SchillerJSLucasJWWardBWPeregoyJASummary health statistics for US adults: National Health Interview Survey, 2010 National Center for Health Statistics. Vital Health StatisticsVital Health Statistics201210252
   Google Scholar
• Clomipramine hydrochloride [prescribing information]Princeton NJSandoz Inc2011
   Google Scholar
• MS Contin® (morphine extended release) [prescribing information]Hazelwood, MOMallinckrodt2010
   Google Scholar
• OxyContin® (oxycodone HCl controlled-release tablets) [prescribing information]Stamford, CTPurdue Pharma LLP2012
   Google Scholar
• DeanMOpioids in renal failure and dialysis patientsJ Pain Symptom Manage200428549750415504625
   PubMed Web of Science ®Google Scholar
• Duragesic® (fentanyl transdermal system) [prescribing information]Raritan, NJOrtho-McNeil-Janssen Pharmaceuticals, Inc2009
   Google Scholar
• American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older PersonsPharmacological management of persistent pain in older personsJ Am Geriatr Soc20095781331134619573219
   PubMed Web of Science ®Google Scholar
• MilneRWNationRLSomogyiAABochnerFGriggsWMThe influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive-care patientsBr J Clin Pharmacol199234153591633068
   PubMed Web of Science ®Google Scholar
• WolffJBiglerDChristensenCBRasmussenSNAndersenHBTønnesenKHInfluence of renal function on the elimination of morphine and morphine glucuronidesEur J Clin Pharmacol19883443533573402521
   PubMed Web of Science ®Google Scholar
• BabulNDarkeACHagenNHydromorphone metabolite accumulation in renal failureJ Pain Symptom Manage19951031841867543126
   PubMed Web of Science ®Google Scholar
• SmithMTNeuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolitesClin Exp Pharmacol Physiol200027752452810874511
   PubMed Web of Science ®Google Scholar
• AngstMSBührerMLötschJInsidious intoxication after morphine treatment in renal failure: delayed onset of morphine-6-glucuronide actionAnesthesiology20009251473147610781294
   PubMed Web of Science ®Google Scholar
• DubsAWiedemeierPCaduffBMorphine poisoning in chronic kidney failure. Morphine-6-glucuronide as a pharmacologically active morphine metaboliteDtsch Med Wochenschr199912430896898 German10464491
   PubMed Web of Science ®Google Scholar
• HagenNAFoleyKMCerboneDJPortenoyRKInturrisiCEChronic nausea and morphine-6-glucuronideJ Pain Symptom Manage1991631251282016556
   PubMed Web of Science ®Google Scholar
• GuayDRAwniWMFindlayJWPharmacokinetics and pharmacodynamics of codeine in end-stage renal diseaseClin Pharmacol Ther198843163713335120
   PubMed Web of Science ®Google Scholar
• TalbottGALynnAMLevyFHZelikovicIRespiratory arrest precipitated by codeine in a child with chronic renal failureClin Pediatr (Phila)19973631711739078419
   PubMed Web of Science ®Google Scholar
• HeidelbaughJJBruderlyMCirrhosis and chronic liver failure: part I. Diagnosis and evaluationAm Fam Physician200674575676216970019
   PubMed Web of Science ®Google Scholar
• CrottyBWatsonKJDesmondPVHepatic extraction of morphine is impaired in cirrhosisEur J Clin Pharmacol19893655015062753069
   PubMed Web of Science ®Google Scholar
• DurninCHindIDGhaniSPYatesDBMolzKHPharmacokinetics of oral immediate-release hydromorphone (Dilaudid IR) in subjects with moderate hepatic impairmentProc West Pharmacol Soc200144838411794005
   PubMedGoogle Scholar
• HabererJPSchoefflerPCoudercEDuvaldestinPFentanyl phar-macokinetics in anaesthetized patients with cirrhosisBr J Anaesth19825412126712707171414
   PubMed Web of Science ®Google Scholar
• SimpsonDMGazdaSBrownSNGX-4010 C118 Study GroupLong-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic painJ Pain Symptom Manage20103961053106420538187
   PubMed Web of Science ®Google Scholar
• CepedaMSFarrarJTBaumgartenMBostonRCarrDBStromBLSide effects of opioids during short-term administration: effect of age, gender, and raceClin Pharmacol Ther200374210211212891220
   PubMed Web of Science ®Google Scholar
• FanoeSHvidtCEgePJensenGBSyncope and QT prolongation among patients treated with methadone for heroin dependence in the city of CopenhagenHeart20079391051105517344330
   PubMed Web of Science ®Google Scholar
• WedamEFBigelowGEJohnsonRENuzzoPAHaigneyMCQT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trialArch Intern Med2007167222469247518071169
   PubMedGoogle Scholar
• PeacockWFHollanderJEDiercksDBLopatinMFonarowGEmermanCLMorphine and outcomes in acute decompensated heart failure: an ADHERE analysisEmerg Med J200825420520918356349
   PubMed Web of Science ®Google Scholar
• GruberEMTschernkoEMAnaesthesia and postoperative analgesia in older patients with chronic obstructive pulmonary disease: special considerationsDrugs Aging200320534736012696995
   PubMed Web of Science ®Google Scholar
• WalkerJMFarneyRJRhondeauSMChronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathingJ Clin Sleep Med20073545546117803007
   PubMed Web of Science ®Google Scholar
• WebsterLRChoiYDesaiHWebsterLGrantBJSleep-disordered breathing and chronic opioid therapyPain Med20089442543218489633
   PubMed Web of Science ®Google Scholar
• TarkkilaPTuominenMLindgrenLComparison of respiratory effects of tramadol and oxycodoneJ Clin Anesth1997975825859347436
   PubMed Web of Science ®Google Scholar
• Codeine sulfate tablets [prescribing information]Columbus, OHRoxane Laboratories, Inc2010
   Google Scholar
• AntmanEMBennettJSDaughertyAFurbergCRobertsHTaubertKAAmerican Heart AssociationUse of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart AssociationCirculation2007115121634164217325246
   PubMed Web of Science ®Google Scholar
• DonnanGAFisherMMacleodMDavisSMStrokeLancet200837196241612162318468545
   PubMed Web of Science ®Google Scholar
• WatsonCPVernichLChipmanMReedKNortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trialNeurology1998514116611719781549
   PubMed Web of Science ®Google Scholar
• BaileyBBuckleyNAAmreDKA meta-analysis of prognostic indicators to predict seizures, arrhythmias or death after tricyclic antidepressant overdoseJ Toxicol Clin Toxicol200442687788815533027
   PubMed Web of Science ®Google Scholar
• FongHKSandsLPLeungJMThe role of postoperative analgesia in delirium and cognitive decline in elderly patients: a systematic reviewAnesth Analg200610241255126616551934
   PubMed Web of Science ®Google Scholar
• LawlorPGThe panorama of opioid-related cognitive dysfunction in patients with cancer: a critical literature appraisalCancer20029461836185311920548
   PubMed Web of Science ®Google Scholar
• MoritaTTakigawaCOnishiHJapan Pain, Rehabilitation, Palliative Medicine, and Psycho-Oncology (PRPP) Study GroupOpioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trialJ Pain Symptom Manage20053019610316043013
   PubMed Web of Science ®Google Scholar
• MoritaTTeiYTsunodaJInoueSChiharaSIncreased plasma morphine metabolites in terminally ill cancer patients with delirium: an intra-individual comparisonJ Pain Symptom Manage200223210711311844630
   PubMed Web of Science ®Google Scholar
• LeungJMSandsLPPaulSJosephTKinjoSTsaiTDoes postoperative delirium limit the use of patient-controlled analgesia in older surgical patients?Anesthesiology2009111362563119672166
   PubMed Web of Science ®Google Scholar
• Nortriptyline hydrochloride solution [prescribing information]Jacksonville, FLRanbaxy Pharmaceuticals Inc2008
   Google Scholar
• Gabapentin oral solution [prescribing information]Gainesville, FLKiel Laboratories, Inc2012
   Google Scholar
• Lyrica oral solution (pregabalin hydrochloride oral solution) [prescribing information]Kalamazoo, MIPfizer Inc2012
   Google Scholar
• StoneMLaughrenTJonesMLRisk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug AdministrationBMJ2009339b288019671933
   PubMed Web of Science ®Google Scholar
• PatornoEBohnRLWahlPMAnticonvulsant medications and the risk of suicide, attempted suicide, or violent deathJAMA2010303141401140920388896
   PubMed Web of Science ®Google Scholar
• GibbonsRDHurKBrownCHMannJJGabapentin and suicide attemptsPharmacoepidemiol Drug Saf201019121241124720922708
   PubMed Web of Science ®Google Scholar
• SullivanMDEdlundMJSteffickDUnützerJRegular use of prescribed opioids: association with common psychiatric disordersPain20051191–39510316298066
   PubMed Web of Science ®Google Scholar
• BarkinRLBarkinSJReexamining the Elderly Patient’s Presentation With DepressionPrim Care Companion J Clin Psychiatry200810541541619158987
   PubMedGoogle Scholar
• Substance Abuse and Mental Health Services AdministrationResults From The 2011 National Survey On Drug Use And Health: Summary Of National FindingsNSDUH Series H-44, HHS Publication No (SMA) 12-4713Rockville, MDFood and Drug Administration2012
   Google Scholar
• ManchikantiLCashKADamronKSManchukondaRPampatiVMcManusCDControlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variablesPain Physician20069321522516886030
   PubMedGoogle Scholar
• KirshKLSmithHSSpecial issues and concerns in the evaluation of older adults who have painClin Geriatr Med2008242263274vi18387455
   PubMed Web of Science ®Google Scholar
• GourlayDLHeitHAAlmahreziAUniversal precautions in pain medicine: a rational approach to the treatment of chronic painPain Med20056210711215773874
   PubMed Web of Science ®Google Scholar